Cargando…
Solid-State Characterization of Different Crystalline Forms of Sitagliptin
Sitagliptin is an inhibitor of the enzyme dipeptidyl peptidase-4, used for the treatment of type 2 diabetes mellitus. The crystal structure of active pharmaceutical solids determines their physical and chemical properties. The polymorphism, solvates and hydrates can influence the free energy, thermo...
Autores principales: | Stofella, Nayana C. F., Veiga, Andressa, Oliveira, Laiane J., Montin, Elisa F., Andreazza, Itamar F., Carvalho Filho, Marco A. S., Bernardi, Larissa S., Oliveira, Paulo R., Murakami, Fábio S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696402/ https://www.ncbi.nlm.nih.gov/pubmed/31344887 http://dx.doi.org/10.3390/ma12152351 |
Ejemplares similares
-
Solid-State Characterization and Compatibility Studies of Penciclovir, Lysine Hydrochloride, and Pharmaceutical Excipients
por: Meira, Rafaela Z. C., et al.
Publicado: (2019) -
Spectrophotometric Methods for the Determination of Sitagliptin and Vildagliptin in Bulk and Dosage Forms
por: El-Bagary, Ramzia I., et al.
Publicado: (2011) -
The physics of large deformation of crystalline solids
por: Bell, James F
Publicado: (1968) -
Diffusion in crystalline solids
por: Murch, G E
Publicado: (1984) -
Non-crystalline solids
por: Frischat, G H
Publicado: (1977)